A compound of general formula wherein R 1 and R 4 are independently selected from the group consisting of hydrogen and (C 1 -C 4)alkyl; R 2 and R 3 are independently selected from the group consisting of hydrogen and (C 1 -C 4)alkyl; or R 2 and R 3 together with the carbon atom to which they are attached form a cyclopropyl, cyclobutyl, cyclopentyl, oxetanyl, tetrahydrofuranyl, or tetrahydropyranyl ring; n = 0, 1 or 2; Q is -O-C -R 5; R 5 is selected from the group consisting of (C 1 -C 6)alkyl, (C 3 -C 6)cycloalkyl, halo(C 1 -C 6)alkyl, (C 1 -C 6)alkoxy, (C 1 -C 6)alkoxy(C 1 -C 6)alkyl, aryl; wherein said aryl is optionally substituted with one or more substituents independently selected from R 6, or wherein said aryl is optionally benzodioxole; and wherein said (C 1 -C 6)alkyl, (C 3 -C 6)cycloalkyl are optionally substituted with one or more substituents independently selected from R 7; R 6 consists of halogen, cyano, hydroxyl, (C 1 -C 4)alkyl, halo(C 1 -C 4)alkyl, (C 1 -C 4)alkyloxy, - S 2 R x, -S 2 NR a R b, -C R x, -C NR a R b and -OR x; R 7 consists of halogen, hydroxyl, cyano, (C 1 -C 4)alk0xy, -C NR a R b, -C OR a, -S 2 R x, -S 2 NR a R b, -OR x, and -SR x; R x consists of (C 1 -C 6)alkyl and (C 3 -C 6)cycloalkyl; R a and R b are independently selected from the group consisting of hydrogen, (C 1 -C 4)alkyl, phenyl-(C 1 -C 4)alkyl, or R a and R b together with the nitrogen to which they are attached form a 4-6 membered heterocycloalkyl, wherein said heterocycloalkyl is optionally substituted with one or more (C 1 -C 4)alkyl, -C R x; or pharmaceutically acceptable salts, hydrates or solvates thereof. R 1 and R 4 are independently selected from the group consisting of hydrogen and (C 1 -C 4)alkyl; R 2 and R 3 are independently selected from the group consisting of hydrogen and (C 1 -C 4)alkyl; or R 2 and R 3 together with the carbon atom to which they are attached form a cyclopropyl, cyclobutyl, cyclopentyl, oxetanyl, tetrahydrofuranyl, or tetrahydropyranyl ring; n = 0, 1 or 2; Q is -O-C -R 5; R 5 is selected from the group consisting of (C 1 -C 6)alkyl, (C 3 -C 6)cycloalkyl, halo(C 1 -C 6)alkyl, (C 1 -C 6)alkoxy, (C 1 -C 6)alkoxy(C 1 -C 6)alkyl, aryl; wherein said aryl is optionally substituted with one or more substituents independently selected from R 6, or wherein said aryl is optionally benzodioxole; and wherein said (C 1 -C 6)alkyl, (C 3 -C 6)cycloalkyl are optionally substituted with one or more substituents independently selected from R 7; R 6 consists of halogen, cyano, hydroxyl, (C 1 -C 4)alkyl, halo(C 1 -C 4)alkyl, (C 1 -C 4)alkyloxy, - S 2 R x, -S 2 NR a R b, -C R x, -C NR a R b and -OR x; R 7 consists of halogen, hydroxyl, cyano, (C 1 -C 4)alk0xy, -C NR a R b, -C OR a, -S 2 R x, -S 2 NR a R b, -OR x, and -SR x; R x consists of (C 1 -C 6)alkyl and (C 3 -C 6)cycloalkyl; R a and R b are independently selected from the group consisting of hydrogen, (C 1 -C 4)alkyl, phenyl-(C 1 -C 4)alkyl, or R a and R b together with the nitrogen to which they are attached form a 4-6 membered heterocycloalkyl, wherein said heterocycloalkyl is optionally substituted with one or more (C 1 -C 4)alkyl, -C R x; or pharmaceutically acceptable salts, hydrates or solvates thereof.